MYNZ logo

Mainz Biomed BV (MYNZ) Company Overview

Profile

Full Name:

Mainz Biomed N.V.

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

Germany

IPO:

November 5, 2021

Indexes:

Not included

Website:

http://mainzbiomed.com

Description:

MYNZ (Mainz Biomed BV) is a biotechnology company focused on developing innovative diagnostic solutions for early disease detection. They specialize in molecular tests, particularly for gastrointestinal diseases, aiming to improve patient outcomes through advanced technology and personalized healthcare solutions.

Key Details

Price

$5.80

Market Cap

$11.61 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$895.50 K(+68.99% YoY)

Annual EPS

-$64.80(+12.90% YoY)

PE Ratio

-

Annual ROE

-303.20%

Annual Debt To Equity

1.84

Beta

0.18

Events Calendar

Earnings

Next earnings date:

Feb 25, 2025

Recent quarterly earnings:

Oct 21, 2024

Recent annual earnings:

Apr 10, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 3, 2024

Analyst ratings

Recent major analysts updates

Feb 14, 25 Maxim Group
Buy
Nov 25, 24 HC Wainwright & Co.
Neutral
Apr 12, 24 Cantor Fitzgerald
Neutral
Mar 6, 24 HC Wainwright & Co.
Buy
Nov 21, 23 Cantor Fitzgerald
Neutral
Nov 20, 23 HC Wainwright & Co.
Buy
Sep 26, 23 Cantor Fitzgerald
Overweight
Sep 22, 23 HC Wainwright & Co.
Buy
Sep 14, 23 Cantor Fitzgerald
Overweight
Aug 22, 23 Cantor Fitzgerald
Overweight

Screeners with MYNZ included

Growing Shares Outstanding
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Earnings next week
Stocks with low beta

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$5.80
MYNZ price is $5.80

Price All-time High

$27.76
MYNZ price is currently -79.11% below its historical high of $27.76

Price Analysts Target

$14.00
MYNZ price is currently -58.58% lower than the consensus analysts' forecast

Price Most Recent Change

+1.74%
MYNZ price was up +1.74% on Feb 22, 2025

Price YTD Change

+33.01%
MYNZ price is up +33.01% since January 1st

Price 3-Year Change

-63.46%
MYNZ price is down -63.46% over the past 3 years

Market cap

Market Cap

$11.61 M
MYNZ market capitalization is $11.61 million

Market Cap 3-Year Change

+113.09%
MYNZ market capitalization is up +113.09% over the past 3 years

Market Cap All-time High

$15.88 M
MYNZ market capitalization is currently -26.87% below its historical high of $15.88 million

Market Cap Sector Rank

18.94%
MYNZ market capitalization is higher than 18.94% of companies in Healthcare sector

Technical

Beta

0.18
MYNZ beta is 0.18

200-day SMA

$1.78
MYNZ price is currently +225.43% above its 200-day simple moving average

14-day RSI

48.79
MYNZ 14-day relative strength index is 48.79

30-day Relative Volume

0.79
MYNZ 30-day relative volume is 0.79

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$895.50 K
MYNZ annual revenue is $895.50 thousand

Annual Revenue Analysts Estimate

$1.06 M
MYNZ annual revenue is currently -15.64% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+68.99%
MYNZ annual revenue is up +68.99% year-on-year

Annual Revenue Sector Rank

12.39%
MYNZ annual revenue is higher than 12.39% of companies in Healthcare sector

Profit

Annual Gross Profit

$509.70 K
MYNZ annual gross profit is $509.70 thousand

Annual Gross Margin

56.91%
MYNZ annual gross profit margin is 56.91%

Annual Operating Profit

-$26.64 M
MYNZ annual operating income is -$26.64 million

Annual Operating Margin

-2975.47%
MYNZ annual operating profit margin is -2975.47%

Annual Net Income

-$26.30 M
MYNZ annual net profit is -$26.30 million

Annual Net Margin

-2936.50%
MYNZ annual net profit margin is -2936.50%

EPS

Annual EPS

-$64.80
MYNZ annual earnings per share is -$64.80

Annual EPS Analysts Estimate

-$23.60
MYNZ annual earnings per share is currently +174.58% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+12.9%
MYNZ annual earnings per share is up +12.9% year-on-year

Annual EPS Sector Rank

4.94%
MYNZ annual earnings per share is higher than 4.94% of companies in Healthcare sector

ROA & ROE

Annual ROA

-147.52%
MYNZ annual return on assets is -147.52%

Annual ROE

-303.20%
MYNZ annual return on equity is -303.20%

EBIT & EBITDA

Annual EBIT

-$25.49 M
MYNZ annual earnings before interest & taxes is -$25.49 million

Annual EBITDA

-$24.62 M
MYNZ annual EBITDA is -$24.62 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MYNZ price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MYNZ price to earnings ratio is unknown

PB Ratio

PB Ratio

-2.81
MYNZ price to book ratio is -2.81

PB Ratio Sector Rank

5.9%
MYNZ price to book ratio is higher than 5.9% of companies in Healthcare sector

PS Ratio

PS Ratio

-
MYNZ price to sales ratio value is unknown

PS Ratio Sector Rank

-
MYNZ price to sales ratio is unknown

Enterprise value

Enterprise Value

$18.91 M
MYNZ enterprise value is $18.91 million

Enterprise Value Sector Rank

28.24%
MYNZ enterprise value is higher than 28.24% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
MYNZ EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
MYNZ EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.97
MYNZ annual current ratio is 0.97

Annual Quick Ratio

0.91
MYNZ annual quick ratio is 0.91

Leverage

Annual Debt To Equity

1.84
MYNZ annual debt to equity ratio is 1.84

Annual Interest Coverage Ratio

-31.48
MYNZ annual interest coverage ratio is -31.48

Risk & Stability

Piotroski F-Score

-
MYNZ piotroski f-score value is unknown

Altman Z-Score

-11.15
MYNZ altman z-score is -11.15

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$15.41 M
MYNZ annual total assets is $15.41 million

Annual Non Current Assets

$6.43 M
MYNZ annual long term assets is $6.43 million

Annual Current Assets

$8.98 M
MYNZ annual total current assets is $8.98 million

Annual Cash & Cash Equivalents

$7.07 M
MYNZ annual cash & cash equivalents is $7.07 million

Equity

Annual Book Value

$3.25 M
MYNZ annual book value is $3.25 million

Annual Working Capital

-$257.10 K
MYNZ annual working capital is -$257.10 thousand

Liabilities

Annual Total Liabilities

$12.16 M
MYNZ annual total liabilities is $12.16 million

Annual Total Long Term Liabilities

$2.92 M
MYNZ annual total long term liabilities is $2.92 million

Annual Current Liabilities

$9.24 M
MYNZ annual total current liabilities is $9.24 million

Annual Accounts Payable

$2.36 M
MYNZ annual accounts payable is $2.36 million

Debt

Annual Total Debt

$7.42 M
MYNZ annual total debt is $7.42 million

Annual Total Debt 1-Year Change

+129.87%
MYNZ annual total debt is up +129.87% year-on-year

Annual Long Term Debt

$2.20 M
MYNZ annual long term debt is $2.20 million

Annual Short Term Debt

$5.22 M
MYNZ annual short term debt is $5.22 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$27.54 M
MYNZ annual total expenses is $27.54 million

Annual Operating Expenses

$27.15 M
MYNZ annual total operating expenses is $27.15 million

Annual Cost Of Goods Sold

$385.80 K
MYNZ annual cost of goods sold is $385.80 thousand

Annual SGA

$17.22 M
MYNZ annual SGA is $17.22 million

Annual D&A

$866.40 K
MYNZ annual depreciation & amortization is $866.40 thousand

Annual Interest Expense

$809.60 K
MYNZ annual interest expense is $809.60 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$21.94 M
MYNZ annual cash flow from operations is -$21.94 million

Annual CFO 1-Year Change

-48.54%
MYNZ annual cash flow from operations is down -48.54% year-on-year

Annual CFI

-$1.90 M
MYNZ annual cash flow from investing activities is -$1.90 million

Annual CFI 1-Year Change

-188.35%
MYNZ annual cash flow from investing activities is down -188.35% year-on-year

Annual CFF

$14.23 M
MYNZ annual cash flow from financing activities is $14.23 million

Annual CFF 1-Year Change

-40.58%
MYNZ annual cash flow from financing activities is down -40.58% year-on-year

Free CashFlow

Annual FCF

-$23.84 M
MYNZ annual free cash flow is -$23.84 million

Annual FCF 1-Year Change

-54.51%
MYNZ annual free cash flow is down -54.51% year-on-year

CAPEX

Annual CAPEX

$1.90 M
MYNZ annual capital expenditures is $1.90 million

Annual CAPEX 1-Year Change

+188.35%
MYNZ annual capital expenditures is up +188.35% year-on-year

Institutional Ownership

Similar stocks

JAGX logo
Jaguar Health (JAGX)
SNSE logo
Sensei Biotherapeutics (SNSE)
INBS logo
Intelligent Bio Solutions (INBS)
SSKN logo
STRATA Skin Sciences (SSKN)
CANF logo
Can-Fite BioPharma (CANF)
BCDA logo
BioCardia (BCDA)
TLPH logo
Talphera (TLPH)
Adagio Medical Holdings (ADGM)
BRTX logo
BioRestorative Therapies (BRTX)

FAQ

  • What is the ticker symbol for Mainz Biomed BV?
  • Does Mainz Biomed BV pay dividends?
  • What sector is Mainz Biomed BV in?
  • What industry is Mainz Biomed BV in?
  • What country is Mainz Biomed BV based in?
  • When did Mainz Biomed BV go public?
  • Is Mainz Biomed BV in the S&P 500?
  • Is Mainz Biomed BV in the NASDAQ 100?
  • Is Mainz Biomed BV in the Dow Jones?
  • When was Mainz Biomed BV's last earnings report?
  • When does Mainz Biomed BV report earnings?
  • Should I buy Mainz Biomed BV stock now?

What is the ticker symbol for Mainz Biomed BV?

The ticker symbol for Mainz Biomed BV is NASDAQ:MYNZ

Does Mainz Biomed BV pay dividends?

No, Mainz Biomed BV does not pay dividends

What sector is Mainz Biomed BV in?

Mainz Biomed BV is in the Healthcare sector

What industry is Mainz Biomed BV in?

Mainz Biomed BV is in the Diagnostics & Research industry

What country is Mainz Biomed BV based in?

Mainz Biomed BV is headquartered in Germany

When did Mainz Biomed BV go public?

Mainz Biomed BV's initial public offering (IPO) was on November 5, 2021

Is Mainz Biomed BV in the S&P 500?

No, Mainz Biomed BV is not included in the S&P 500 index

Is Mainz Biomed BV in the NASDAQ 100?

No, Mainz Biomed BV is not included in the NASDAQ 100 index

Is Mainz Biomed BV in the Dow Jones?

No, Mainz Biomed BV is not included in the Dow Jones index

When was Mainz Biomed BV's last earnings report?

Mainz Biomed BV's most recent earnings report was on Oct 21, 2024

When does Mainz Biomed BV report earnings?

The next expected earnings date for Mainz Biomed BV is Feb 25, 2025

Should I buy Mainz Biomed BV stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions